Table 1.
Demographic and functional data of all included subject.
| Patient-Level Data | Controls | All Patients | Group 1 | Group 2 | Group 3 |
|---|---|---|---|---|---|
| Patients (n) | 54 | 156 | 71 | 55 | 30 |
| Sex (F/M) | 35/19 | 101/55 | 46/25 | 36/19 | 19/11 |
| Age at Exam (Y)A | 39.24 ± 16.00 | 38.77 ± 18.23 | 33.76 ± 15.17 | 45.03 ± 19.521 | 39.15 ± 18.79 |
| Age of Onset (Y)A | --- | 26.39 ± 17.16 | 24.75 ± 15.48 | 32.91 ± 18.93 | 18.30 ± 12.59 |
| Disease Duration (Y)A | --- | 12.39 ± 12.45 | 9.01 ± 9.55 | 12.12 ± 12.00 | 20.85 ± 15.07 |
| Eye-Level Data | |||||
| Eyes (n) | 108 | 311 | 142 | 109 | 60 |
| BCVA (LogMAR)A | 0.00 ± 0.00 | 0.68 ± 0.47 | 0.57 ± 0.44 | 0.62 ± 0.43 | 1.06 ± 0.4 |
| Refractive Error (Dpt)A | −0.80 ± 2.05 | −1.15 ± 1.99 | −1.23 ± 2.05 | −0.64 ± 1.95 | −1.88 ± 1.67 |
| Foveal Status (FI/FNI) | --- | 197/114 | 79/63 | 65/44 | 53/7 |
A Values indicate mean ± standard deviation. BCVA: best corrected visual acuity, dpt: diopters, f: female, FI: foveal involvement, FNI: foveal non-involvement, LogMAR: logarithm of the minimum angle of resolution, M: Male, Y: Years.